ArticleOncotarget2017

NF-κB1, c-Rel, and ELK1 inhibit miR-134 expression leading to TAB1 upregulation in paclitaxel-resistant human ovarian cancer.

Ting Shuang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.